fashion -WSS

fashion

author：focus 2025-09-04 04:25:10 - browse：7511

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Rep. Raul Ruiz on the physician shortage and more

WSS

Takeda, Janssen join wearable maker to measure scratching

J&J to emphasize cancer drugs, stop much of its vaccine research

Takeda, Janssen join wearable maker to measure scratching

Chemotherapy shortages won’t get better under Biden’s latest plan

Pregnancy discrimination could be enabled by AI

Fetal surgery at risk from Dobbs and new abortion restrictions

Wikipedia

fashion

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Medical leaders decry Supreme Court decision on affirmative action

U.K. Biobank has 500,000 peoples' genome sequences available

Psychedelics group wrestles with new pharma identity

With clinical trial data readouts, here's how to spot spin

Duchenne breakthrough therapy leaves behind pioneering families

U.K. Biobank has 500,000 peoples' genome sequences available

At least 13 dead in Texas as scorching temps continue

Congenital heart disease patients face new threat of heart failure

focus

Fetal surgery at risk from Dobbs and new abortion restrictions

Flagship Pioneering launches a new biotech in two countries

In diabetes hearing, Sanders takes on a new foe: food makers

What to do when lifesaving products contribute to climate change

Pregnancy discrimination could be enabled by AI

J&J to emphasize cancer drugs, stop much of its vaccine research

entertainment

focus

knowledge

hotspot